M. Rahman

Beraprost as initial pharmacologic treatment for pulmonary hypertension related to left to right shunt congenital heart disease.

T. Ontoseno, Shirley Ferlina Lasmono, M. Rahman, 2021 .

Risk Factors for Coronary Artery Aneurysm in Children with Kawasaki Disease: A Case-control Study

D. Wulandari, T. Ontoseno, I. K. A. Utamayasa, 2022, Journal of Medical and Health Studies.

Pulmonary Artery Hypertension in Acyanotic Congenital Heart Disease Underwent Transcatheter Closure at Dr. Soetomo Hospital

T. Ontoseno, I. K. A. Utamayasa, T. Hidayat, 2021, Indian Journal of Forensic Medicine & Toxicology.

Profile of Age and Sex of Congenital Rubella Syndrome Patients with Congenital Heart Disease

W. Retnowati, M. Rahman, Chaq El Chaq Zamzam Multazam, 2021 .

Correlation between serum myeloperoxidase with the severity of heart failure in children

G. Prabowo, Ratih Kumala Sari, A. F. Athiyyah, 2022, International journal of health sciences.

BODY MASS INDEX (BMI) OF CHILDREN WITH TETRALOGY OF FALLOT (TOF)

V. Kalanjati, M. Rahman, Ovin Nada Saputri, 2020, Majalah Biomorfologi.

Risk factors for mortality in children with cyanotic congenital heart disease associated with brain abscess

P. Gunawan, M. Rahman, R. Noviandi, 2022, International journal of health sciences.